it is being funded by the wellcome trust the bill and melinda gates foundation the world economic forum the governments of norway germany japan and india as of april 2018 it has invested 37 5 million in austria based themis bioscience and 56 million in us based inovio pharmaceuticals inc to develop vaccine candidates against lassa fever and mers they published a study in the lancet in 2018 which estimated the costs of developing vaccines for diseases that could escalate into global humanitarian crises they focused on 11 diseases which cause relatively few deaths at present and primarily strike the poor they estimated that it would cost between 2 8 billion and 3 7 billion to develop at least one vaccine for each of them this should be set against the potential cost of an outbreak the 2003 sars outbreak in east asia cost 54 billion